# SLX4

## Overview
The SLX4 gene encodes the SLX4 structure-specific endonuclease subunit, a pivotal protein involved in DNA repair mechanisms. This protein functions as a scaffold for various nucleases, including SLX1, MUS81-EME1, and XPF-ERCC1, facilitating the resolution of complex DNA structures such as Holliday junctions and interstrand crosslinks. As a multidomain protein, SLX4 contains domains like the SAF-A/B, Acinus, and PIAS (SAP) domain, which are crucial for DNA binding and substrate recognition, and a conserved C-terminal domain (CCD) that enhances nuclease activity through interaction with SLX1. SLX4 plays a significant role in maintaining genomic stability by participating in homology-directed repair and telomere maintenance. Mutations in the SLX4 gene are linked to clinical conditions such as Fanconi anemia and an increased risk of certain cancers, underscoring its importance in both genetic disorders and cancer susceptibility (Bogliolo2015Fanconi; Svendsen2009Mammalian; Muñoz2009Coordination).

## Structure
The SLX4 protein, also known as the SLX4 structure-specific endonuclease subunit, is a multidomain protein involved in DNA repair processes. It contains several domains that facilitate its function as a scaffold for various endonucleases. The primary structure of SLX4 includes domains such as the SAF-A/B, Acinus, and PIAS (SAP) domain, and a conserved C-terminal domain (CCD) (Xu2021Structure; Payliss2021Exploring). The SAP domain is involved in DNA binding and is essential for substrate recognition and cleavage site selection (Xu2021Structure). The CCD domain interacts with the SLX1 protein, enhancing its nuclease activity (Xu2021Structure).

The secondary structure of SLX4 includes α-helices, particularly in the CCD domain, which is composed of five α-helices (Xu2021Structure). The tertiary structure of SLX4 involves interactions between its domains, such as hydrophobic interactions between the SAP and CCD domains (Xu2021Structure). The quaternary structure of SLX4 is characterized by its interaction with SLX1, forming a heterodimer essential for DNA cleavage (Xu2021Structure).

SLX4 is subject to post-translational modifications, including phosphorylation, which can regulate its activity. It also has splice variant isoforms that may influence its function in DNA repair pathways (Payliss2021Exploring).

## Function
The SLX4 gene encodes a protein that plays a crucial role in DNA repair processes in human cells. SLX4 acts as a scaffold for various structure-specific nucleases, including SLX1, MUS81-EME1, and XPF-ERCC1, coordinating their activities to process complex DNA structures such as Holliday junctions (HJs) and branched DNA intermediates. This coordination is essential for the resolution of DNA double-strand breaks (DSBs) and interstrand crosslinks (ICLs), which are critical for maintaining genomic stability (Muñoz2009Coordination).

SLX4 is involved in homology-directed repair (HDR), an error-free repair mechanism for DSBs, and acts as a Holliday junction resolvase, facilitating the separation of these structures into double-stranded DNA molecules (Svendsen2009Mammalian). The protein is also implicated in the repair of replication forks blocked by ICLs and in the cleavage of nonhomologous tails during homologous recombination (Muñoz2009Coordination).

SLX4 is active in the nucleus, where it assembles a multiprotein complex that includes components of the telomere shelterin complex and the mismatch repair complex, highlighting its role in telomere maintenance and DNA repair (Svendsen2009Mammalian). Its function is critical for cellular resistance to DNA-damaging agents and for ensuring proper cell cycle progression (Svendsen2009Mammalian).

## Clinical Significance
Mutations in the SLX4 gene are associated with several clinical conditions, most notably Fanconi anemia (FA) and certain cancers. Biallelic mutations in SLX4 can lead to a subtype of Fanconi anemia known as FA-P, characterized by bone marrow failure, chromosome instability, and congenital abnormalities (Bogliolo2015Fanconi; Schuster2012Whole). These mutations result in a deficiency in DNA repair processes, contributing to the clinical manifestations of FA (Schuster2012Whole).

Monoallelic mutations in SLX4 have been linked to an increased risk of breast and ovarian cancer. Studies have identified SLX4 mutations in breast cancer patients who are negative for BRCA1/2 mutations, suggesting a potential role in cancer susceptibility (de2012Low; Shah2013Assessment). The p.W823* truncating mutation in SLX4, for instance, has been associated with breast cancer, as it impairs the gene's function in DNA repair (Shah2013Assessment).

SLX4 mutations also influence the response to certain anticancer drugs. Alterations in SLX4 can affect sensitivity to DNA synthesis inhibitors and topoisomerase inhibitors, impacting treatment outcomes (Sousa2015Alterations). These findings highlight the clinical significance of SLX4 in both genetic disorders and cancer therapy.

## Interactions
The SLX4 protein, also known as the SLX4 structure-specific endonuclease subunit, is a crucial scaffold for various DNA repair nucleases. It interacts with several proteins, forming a complex that includes SLX1, MUS81-EME1, and XPF-ERCC1, which are essential for DNA repair processes such as resolving Holliday junctions and interstrand crosslink (ICL) repair (Svendsen2009Mammalian; Muñoz2009Coordination). SLX4 directly interacts with SLX1 and XPF, but not with ERCC1, as demonstrated by two-hybrid analysis and co-immunoprecipitation experiments (Muñoz2009Coordination). 

SLX4 also associates with other proteins, including PLK1, TERF2, TERF2IP, and the MSH2-MSH3 mismatch repair complex, indicating its role in broader DNA repair and telomere maintenance functions (Svendsen2009Mammalian). The interaction with XPF-ERCC1 is particularly important for ICL repair, mediated by the MUS312/MEI9 interaction-like (MLR) domain of SLX4 (Hoogenboom2018The). 

SLX4's interactions are not limited to stable complexes; it also participates in dynamic processes, such as being recruited to sites of DNA damage and enhancing the activity of associated nucleases like SLX1 and MUS81 (Svendsen2009Mammalian; Muñoz2009Coordination). These interactions underscore SLX4's pivotal role in maintaining genomic stability.


## References


[1. (Hoogenboom2018The) Wouter S Hoogenboom, Rick A C M Boonen, and Puck Knipscheer. The role of slx4 and its associated nucleases in dna interstrand crosslink repair. Nucleic Acids Research, 47(5):2377–2388, December 2018. URL: http://dx.doi.org/10.1093/nar/gky1276, doi:10.1093/nar/gky1276. This article has 22 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gky1276)

[2. (Sousa2015Alterations) Fabricio G. Sousa, Renata Matuo, Sai-Wen Tang, Vinodh N. Rajapakse, Augustin Luna, Chris Sander, Sudhir Varma, Paul H.G. Simon, James H. Doroshow, William C. Reinhold, and Yves Pommier. Alterations of dna repair genes in the nci-60 cell lines and their predictive value for anticancer drug activity. DNA Repair, 28:107–115, April 2015. URL: http://dx.doi.org/10.1016/j.dnarep.2015.01.011, doi:10.1016/j.dnarep.2015.01.011. This article has 60 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.dnarep.2015.01.011)

[3. (Xu2021Structure) Xiang Xu, Mingzhu Wang, Jixue Sun, Zhenyu Yu, Guohong Li, Na Yang, and Rui-Ming Xu. Structure specific dna recognition by the slx1–slx4 endonuclease complex. Nucleic Acids Research, 49(13):7740–7752, June 2021. URL: http://dx.doi.org/10.1093/nar/gkab542, doi:10.1093/nar/gkab542. This article has 16 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkab542)

[4. (Schuster2012Whole) Beatrice Schuster, Kerstin Knies, Chantal Stoepker, Eunike Velleuer, Richard Friedl, Birgit Gottwald-Mühlhauser, Johan P. de Winter, and Detlev Schindler. Whole exome sequencing reveals uncommon mutations in the recently identified fanconi anemia geneslx4/fancp. Human Mutation, 34(1):93–96, October 2012. URL: http://dx.doi.org/10.1002/humu.22221, doi:10.1002/humu.22221. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.22221)

[5. (Payliss2021Exploring) Brandon J. Payliss, Ayushi Patel, Anneka C. Sheppard, and Haley D. M. Wyatt. Exploring the structures and functions of macromolecular slx4-nuclease complexes in genome stability. Frontiers in Genetics, November 2021. URL: http://dx.doi.org/10.3389/fgene.2021.784167, doi:10.3389/fgene.2021.784167. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2021.784167)

[6. (Shah2013Assessment) Sohela Shah, Yonghwan Kim, Irina Ostrovnaya, Rajmohan Murali, Kasmintan A. Schrader, Francis P. Lach, Kara Sarrel, Rohini Rau-Murthy, Nichole Hansen, Liyng Zhang, Tomas Kirchhoff, Zsofia Stadler, Mark Robson, Joseph Vijai, Kenneth Offit, and Agata Smogorzewska. Assessment of slx4 mutations in hereditary breast cancers. PLoS ONE, 8(6):e66961, June 2013. URL: http://dx.doi.org/10.1371/journal.pone.0066961, doi:10.1371/journal.pone.0066961. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0066961)

[7. (Bogliolo2015Fanconi) Massimo Bogliolo and Jordi Surrallés. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics. Current Opinion in Genetics &amp; Development, 33:32–40, August 2015. URL: http://dx.doi.org/10.1016/j.gde.2015.07.002, doi:10.1016/j.gde.2015.07.002. This article has 205 citations.](https://doi.org/10.1016/j.gde.2015.07.002)

[8. (Svendsen2009Mammalian) Jennifer M. Svendsen, Agata Smogorzewska, Mathew E. Sowa, Brenda C. O’Connell, Steven P. Gygi, Stephen J. Elledge, and J. Wade Harper. Mammalian btbd12/slx4 assembles a holliday junction resolvase and is required for dna repair. Cell, 138(1):63–77, July 2009. URL: http://dx.doi.org/10.1016/j.cell.2009.06.030, doi:10.1016/j.cell.2009.06.030. This article has 375 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2009.06.030)

[9. (Muñoz2009Coordination) Ivan M. Muñoz, Karolina Hain, Anne-Cécile Déclais, Mary Gardiner, Geraldine W. Toh, Luis Sanchez-Pulido, Johannes M. Heuckmann, Rachel Toth, Thomas Macartney, Berina Eppink, Roland Kanaar, Chris P. Ponting, David M.J. Lilley, and John Rouse. Coordination of structure-specific nucleases by human slx4/btbd12 is required for dna repair. Molecular Cell, 35(1):116–127, July 2009. URL: http://dx.doi.org/10.1016/j.molcel.2009.06.020, doi:10.1016/j.molcel.2009.06.020. This article has 281 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.molcel.2009.06.020)

[10. (de2012Low) Gorka Ruiz de Garibay, Avellaneda Díaz, Belén Gaviña, Atocha Romero, Pilar Garre, Ana Vega, Ana Blanco, Alicia Tosar, Orland Díez, Pedro Pérez-Segura, Eduardo Díaz-Rubio, Trinidad Caldés, and Miguel de la Hoya. Low prevalence of slx4 loss-of-function mutations in non-brca1/2 breast and/or ovarian cancer families. European Journal of Human Genetics, 21(8):883–886, December 2012. URL: http://dx.doi.org/10.1038/ejhg.2012.268, doi:10.1038/ejhg.2012.268. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2012.268)